Recruiting OBSERVATIONAL NCT06744296
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck (MRD-DUCHESS)
Sponsor: Haystack Oncology, Inc.
Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
Blood Draws and Tissue Sample(s)
Updated 3 times since 2025 Last updated: May 14, 2025 Started: Feb 3, 2025 Primary completion: Jan 6, 2027 Completion: Jan 6, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06744296, this observational or N/A phase trial focuses on Squamous Cell Carcinoma of Head and Neck and remains actively recruiting participants. Sponsored by Haystack Oncology, Inc., it has been updated 3 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
3 versions recorded-
Jun 2025 — Present [monthly]
Recruiting
-
Mar 2025 — Jun 2025 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2025 — Mar 2025 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Haystack Oncology, Inc.
- Massachusetts Eye and Ear Infirmary
Data source: Massachusetts Eye and Ear Infirmary
For direct contact, visit the study record on ClinicalTrials.gov .